Wall Street analysts forecast that Kraton Corp (NYSE:KRA) will report $364.55 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Kraton’s earnings. The highest sales estimate is $367.00 million and the lowest is $362.10 million. Kraton reported sales of $444.22 million during the same quarter last year, which indicates a negative year-over-year growth rate of 17.9%. The firm is scheduled to report its next earnings results on Wednesday, October 28th.
According to Zacks, analysts expect that Kraton will report full year sales of $1.52 billion for the current year, with estimates ranging from $1.51 billion to $1.52 billion. For the next fiscal year, analysts anticipate that the business will report sales of $1.61 billion, with estimates ranging from $1.59 billion to $1.63 billion. Zacks’ sales averages are an average based on a survey of research analysts that that provide coverage for Kraton.
Kraton (NYSE:KRA) last released its earnings results on Wednesday, July 29th. The specialty chemicals company reported $0.30 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.22. The firm had revenue of $355.68 million for the quarter, compared to analysts’ expectations of $370.70 million. Kraton had a return on equity of 3.64% and a net margin of 12.08%.
Several research analysts have commented on the stock. Loop Capital decreased their price objective on shares of Kraton from $34.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, August 4th. Zacks Investment Research cut shares of Kraton from a “buy” rating to a “hold” rating in a report on Friday, June 12th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. Kraton has a consensus rating of “Hold” and a consensus price target of $18.83.
Shares of KRA stock traded down $0.03 during mid-day trading on Tuesday, hitting $14.65. 194,644 shares of the stock were exchanged, compared to its average volume of 243,959. The stock has a market capitalization of $466.79 million, a price-to-earnings ratio of 2.39 and a beta of 3.07. Kraton has a 12-month low of $4.45 and a 12-month high of $35.00. The stock’s fifty day simple moving average is $15.51 and its two-hundred day simple moving average is $13.39. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.85 and a current ratio of 1.84.
Several hedge funds and other institutional investors have recently made changes to their positions in KRA. Principal Financial Group Inc. grew its holdings in Kraton by 47.3% during the second quarter. Principal Financial Group Inc. now owns 354,280 shares of the specialty chemicals company’s stock valued at $6,122,000 after purchasing an additional 113,749 shares during the period. Quadrature Capital Ltd acquired a new position in Kraton during the second quarter valued at approximately $179,000. FMR LLC acquired a new position in Kraton during the second quarter valued at approximately $657,000. Charles Schwab Investment Management Inc. grew its holdings in Kraton by 0.5% during the second quarter. Charles Schwab Investment Management Inc. now owns 420,015 shares of the specialty chemicals company’s stock valued at $7,258,000 after purchasing an additional 1,916 shares during the period. Finally, AQR Capital Management LLC grew its holdings in Kraton by 5.3% during the second quarter. AQR Capital Management LLC now owns 98,967 shares of the specialty chemicals company’s stock valued at $1,710,000 after purchasing an additional 4,992 shares during the period. 93.47% of the stock is owned by institutional investors.
Kraton Corporation manufactures and sells styrenic block copolymers and other engineered polymers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Polymer and Chemical. The Polymer segment offers performance products, including styrene-butadiene-styrene and styrene-isoprene-styrene; and specialty polymers, such as hydrogenated styrenic block copolymers, as well as isoprene rubber and isoprene rubber latex for use in medical and personal care products, adhesives, tackifiers, paints, and coatings.
Read More: Why do companies engage in swaps?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Kraton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kraton and related companies with MarketBeat.com's FREE daily email newsletter.